Skip to main content
Log in

Significance of Australia antigen in patients after kidney transplantation

  • Kurze Wissenschaftliche Mitteilungen
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In patients under immunosuppressive therapy after kidney transplantation, the presence of Australia antigen frequently correlated with elevated serum transaminases. Therefore, parenchymal liver damage in such patients may be caused by subclinical viral hepatitis taking a mild but prolonged course.

Zusammenfassung

Bei 13 Patienten wurde Australia Antigen vor und nach Nierentransplantation im Krankheitsverlauf verfolgt. 6 Patienten waren vor und nach der Transplantation Antigenträger, einer entwickelte eine Antigenämie nach der Transplantation, 2 Patienten hatten Antikörper gegen Australia Antigen. Bei 4 Patienten wurden weder Au/SH-Antigen noch Antikörper gegen Australia Antigen gefunden. Bei 5 der 7 Australia Antigen-positiven Patienten und einem Patienten mit Antikörper, nicht dagegen bei 4 Australia Antigennegativen Patienten, wurden unter immunsuppressiver Therapie erhöhte Transaminaswerte im Serum festgestellt. Als Ursache der Leberparenchymschädigung bei diesen Patienten kann daher eine subklinisch aber protrahiert verlaufende akute Virushepatitis angenommen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Almeida, J. D., Waterson, A. P.: Das Australia Antigen und seine Beziehungen zur Hepatitis. Internist (Berl.)11, 73 (1970).

    Google Scholar 

  2. Blumberg, B. S., Sutnick, A. J., London, W. T., Millman, J.: Australia antigen and hepatitis. New Engl. J. Med.283, 349 (1970).

    Google Scholar 

  3. —— —— —— Australia antigen and hepatitis. J. Amer. med. Ass.207, 1895 (1969).

    Google Scholar 

  4. Clark, P. A., Hsia, Y. E., Huntsman, R. G.: Toxic complications of treatment with 6-mercaptopurine: 2 cases with hepatic necrosis and intestinal ulcerations. Brit. med. J.1960 I, 393.

    Google Scholar 

  5. Cossart, Y., Taylor, P. E., Vahrman, J., Zuckerman, A. J.: Australia-SH-antigen in hepatitis patients in London. Brit. med. J.1969 III, 755.

    Google Scholar 

  6. Editorials: Hepatitis virus and renal dialysis. Lancet1969 II, 989.

  7. Einhorn, M., Davidsohn, J.: Hepatotoxity of mercaptopurine. J. Amer. med. Ass.188, 802 (1964).

    Google Scholar 

  8. Hill, R. B., Porter, K. A., Massion, C. G.: Hepatic reaction to renal transplants modified by immunosuppressive therapy. Arch. Path.81, 71 (1966).

    Google Scholar 

  9. Hirschman, R., Shulman, N. R., Barker, L. F., Smith, K. O.: Virus-like particles in sera of patients with infectious and serum-hepatitis. J. Amer. med. Ass.208, 1667 (1969).

    Google Scholar 

  10. Krugman, S., Giles, J. P.: Viral hepatitis. J. Amer. med. Ass.212, 1019 (1970).

    Google Scholar 

  11. Penn, I., Hammond, W., Bell, P., McGuire, R., Hutt, M., Starzl, T. E.: Hepatic disorders in renal homograft recipients. Curr. Top. Surg. Res.1, 67 (1969).

    Google Scholar 

  12. Del Prete, S., Constantino, D., Doglia, M., Lorenzelli, A.: Importanza dell' antigene epatitico Au nella diagnosi dell' epatite da virus. Minerva med.60, 5195 (1969).

    Google Scholar 

  13. Prince, A. M.: An antigen detected in the blood during the incubation period of serum hepatitis. Proc. nat. Acad. Sci. (Wash.)60, 814 (1968).

    Google Scholar 

  14. Purcell, R. H., Holland, P. V., Walsh, J. H., Wong, D. C., Morrow, A. G., Chanock, R. M.: A complement-fixation test for measuring Australia antigen and antibody. J. infect. Dis.120, 383 (1969).

    Google Scholar 

  15. Reed, W., Lucas, Z. J., Cohn, R.: Renal transplantation in patients with Australia antigenemie. III. Internat. Congr. of the Transplantation Soc., Den Haag, 7.–11. 9. 1970.

  16. Ringertz, O., Nyström, B.: Hepatitis in a hemodialysis unit. Lancet1969 II, 745.

    Google Scholar 

  17. Sanwald, R., Ritz, E., Rapp, W., Andrassy, K., Kommerell, B.: SH-Antigen bei Dauerdialyse-Patienten. Dtsch. med. Wschr.95, 253 (1970).

    Google Scholar 

  18. Shulman, N. R., Barker, L. F.: Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science165, 304 (1969).

    Google Scholar 

  19. Starzl, T. E., Marchioro, T. L., Poter, K. A.: Progress in homotransplantation of the liver. Advanc. Surg.2, 295 (1966).

    Google Scholar 

  20. —— —— —— Taylor, P. D., Faris, T. D., Herrman, T. J., Hlad, C. J., Waddel, R. W.: Factors determining short and long term survival after orthotopic liver homotransplantation in the dog. Surgery58, 131 (1965).

    Google Scholar 

  21. Turner, G. C., White, B.: SH-antigen in hemodialysis associated hepatitis. Lancet1969 II, 121.

    Google Scholar 

  22. Worth, W. S.: Azathioprine effect on normal canine liver and kidney function. Toxicol. appl. Pharmacol.12, 1 (1968).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

A preliminary report was read at the Vth International Congress of Infectious Diseases, Vienna, 31. 8.–5. 9. 1970.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, R., Wonigeit, K., Bahlmann, J. et al. Significance of Australia antigen in patients after kidney transplantation. Klin Wochenschr 49, 768–769 (1971). https://doi.org/10.1007/BF01495501

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01495501

Keywords

Navigation